A systematic review and meta-analysis on controlled treatment trials of metacognitive therapy for anxiety disorders
|
|
- Miranda Rice
- 5 years ago
- Views:
Transcription
1 Review Article A systematic review and meta-analysis on controlled treatment s of metacognitive therapy for anxiety disorders Ramin Sadeghi, Naghmeh Mokhber 1, Leili Zarif Mahmoudi, Negar Asgharipour 1, Hamid Seyfi 1 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, 1 Psychiatry and Behavioral Sciences Research Center, Ibne Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Background: To conduct a systematic review and meta-analysis on controlled treatment s of meta-cognitive therapy for anxiety disorders. Materials and Methods: Studies were included if they employed controlled methodology and treated people above 18 years with anxiety disorders. Case studies (with less than 4 cases) and single case designed studies were excluded. A comprehensive literature search identified 15 s for systematic review. Results: All included studies showed better treatment results in the MCT arms compared to the control groups. We also statistically pooled the results across studies (when possible). The meta-analyses also showed that MCT had statistically significant better results compared to the control groups in GAD (both immediately post-treatment and 12 months post-therapy results), OCD, and PTSD (p-values ranged < ). Conclusion: Based on the results of our systematic review, MCT seems to be an effective treatment for anxiety disorders and can effectively control their psychological problems. Key words: Anxiety disorders, meta-analysis, meta-cognitive therapy How to cite this article: Sadeghi R, Mokhber N, Mahmoudi LZ, Asgharipour N, Seyfi H. A systematic review and meta-analysis on controlled treatment s of metacognitive therapy for anxiety disorders. J Res Med Sci 2015;20: INTRODUCTION The two most prevalent mental health problems in the general medical setting are anxiety and depression. These two disorders are prevalent, disabling, and often untreated in primary care and have a huge burden on health economy. [1] According to USA National Comorbidity Survey Replication, anxiety disorders are the most prevalent class (28.8%) among mood, impulse-control, and substance use disorders. Among anxiety disorders, the more prevalent 12-month disorders were specific phobia (8.7%) and social phobia (6.8%). [2] Anxiety disorders impose a high burden and in comparison with other psychiatric disorders cause more uncertainty feeling and fear for patients. Unlike Access this article online Quick Response Code: Website: DOI: **** social anxiety disorder that is caused by a special event (such as speaking in public or a first date), generalized anxiety disorders (GAD) last at least 6 months and can get worse if left untreated. [3,4] Some new therapies for anxiety disorders are available, that can help some patients with anxiety disorders to lead productive, more joyful lives. Although cognitive and behavioral therapies (CBT) have produced large effect sizes (ES) for individually delivered treatments (van Balkom et al.), one of the major challenges in these therapies is to make effective treatments more readily available for the patients. [5,6] The aim of CBT is changing maladaptive beliefs and behaviors. Although CBT can have beneficial effects on many patients, their therapeutic effect is still under question. [7] This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. For reprints contact: reprints@medknow.com Address for correspondence: Prof. Negar Asgharipour, Assistant Professor of Clinical Psychology, Psychiatry and Behavioral Sciences Research Center, Ibne Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. asgharipourn@mums.ac.ir Received: ; Revised: ; Accepted: Journal of Research in Medical Sciences Published by Wolters Kluwer - Medknow September 2015
2 For the first time, Wells and Matthews presented a metacognitive model for treatment of emotional disorders. The term metacognition refers to any kind of cognitive process that provided cognitive evaluation or control. [8] Metacognition has a main role in forming and developing anxiety disorders. This is the reason that metacognitive therapy (MCT) has emerged to address deficiency in CBT. Self-regulatory executive function model is the way to understand how cognition and behavior interaction works in the maintenance of anxiety disorders. Based on this perspective, metacognitive beliefs and emotional disorders have positive relationship. [9,10] Metacognitive model of anxiety disorders tries to adjust erroneous negative metacognitive beliefs, positive metacognitive beliefs, and the unhelpful thought-control strategies. In this method, patients should learn new ways of relating to inner thoughts that act as triggers for worrying. In addition, MCT modifies the meaning and consequences of intrusive thoughts and feelings, and beliefs about the necessity of doing rituals. [11] In case of posttraumatic stress disorder (PTSD), this type of therapy helps patients to develop flexible metacognitive awareness and control, and also to free themselves from worry/rumination, and threat monitoring. [12] Several studies showed the effectiveness of MCT on all types of anxiety disorders thus far, [12-15] however, no comprehensive literature review exists in this regard. In this study, we conducted a comprehensive literature search on the efficacy of MCT on anxiety disorders and provided the results in a systematic review and meta-analysis format. METHODS The PRISMA statement was followed for the conduction of the current systematic review ( Search strategy The following databases were searched for the possible relevant studies: PubMed, Scopus, Scholar Google, Cochrane database, and Psycinfo. (Meta-cognition OR metacognitive) AND (anxiety OR Generalized Anxiety Disorder (GAD) OR Obsessive-Compulsive Disorder (OCD) OR Post Traumatic Stress Disorder (PTSD) OR phobia) were used as keywords to search the above-mentioned databases. No language or date limit was imposed on the search. Two authors conducted the search independently. Inclusion criteria All studies used metacognitive treatment for anxiety disorders with the following criteria were included: 1. Participants should be above 18 and have met full criteria for any of anxiety disorders including GAD, OCD, PTSD, specific and social phobia, and panic disorder. 2. Only controlled studies (i.e., studies with a control group) were included: Case studies (with <4 cases) and single case designed studies were excluded. Study selection was done by two authors independently. Duplicate studies were discussed, and only the most recent reports were included. References of the included studies were hand searched in order not to miss any possible relevant study. Statistical analyses Studies with enough quantitative data were further analyzed by meta-analysis. At least sample size, pre- and post-therapy means, and standard deviations for psychological tests scores in MCT and control arms were needed for meta-analysis. Means and standard deviations of difference in pre- and post-treatment scores were calculated according to Cochrane Collaboration guidelines for quantitative data processing. The calculated ES for each study was standardized difference in means of pre- and post-treatment psychological test score changes (MCT compared to the control arms). Random effects model was used to pool the ES across the included studies. [16] Cochrane Q value was used to evaluate the heterogeneity across studies, and P < 0.05 were considered statistically significant. I 2 index was used to quantify the amount of heterogeneity. All statistical analyses were performed using comprehensive meta-analysis version 2. RESULTS PRISMA flowchart of the study is shown in Figure 1. As shown in Figure studies finally met our inclusion criteria. Table 1 shows the characteristics of the included studies. Tables 2 and 3 shows the quality assessment of the Figure 1: PRISMA flowchart of the study Journal of Research in Medical Sciences September
3 included studies according to the Oxford Center for Evidence-Based Medicine checklist for randomized controlled s (s) and New Castle Othawa Quality Assessment Scale. [17] Qualitative synthesis Generalized anxiety disorders Three studies were conducted on GAD patients. Wells et al. compared MCT and applied relaxation (AR) in an. Table 1: The characteristics of the included studies Title Year First author Disorder Site of the study A pilot randomized of metacognitive therapy versus AR in the treatment of adults with GAD on the effectiveness of metacognitive therapy and IUT for GAD Comparison of metacognitie therapy, fluvoxamine and combined treatment in improving metacognitie beliefs and subjective distress of patients with obsessive compulsive disorder Effect of Wells metacognitive therapy on thought fusion in patients with obsessive compulsive disorder The effect of metacognitive and drug therapies on metacognitive beliefs of disease with OCD Efficacy of metacognitive behavioral therapy in reducing self-punishment in patients with PTSD Effects of metacognitive therapy on symptoms of social phobia patients Effects of metacognitive therapy on symptoms of fear of negative judgments in social phobia patients Effects of metacognitive therapy on metacognitive beliefs and cognitive confidence in social phobia patients Comparison effect of meta cognitive therapy and drug on obsession The efficacy of metacognitive therapy on patients suffering from pure obsession Efficacy of metacognitivebehavioral therapy on panic beliefs in female panic patients Wells GAD UK Trait-anxiety subscale of the STAI-T PSWQ BAI MCQ 2012 van der Heiden GAD Netherlands PSWQ STAI-T (SCL-90) MCQ The IUS 2010 Sharreh OCD Iran SUD MCQ (global) MCQ1 a Tests Control Sample size Type of study MCQ2 b MCQ3 c MCQ4 d MCQ5 e AR group MCT: 10 Control: 10 Journal of Research in Medical Sciences September 2015 IUT DT Three group: MCT fluvoxamine and combined treatment 2010 Khorramdel OCD Iran TFI Control: No treatment 2011 Abolghasemi OCD Iran MCQ obsessivecompulsive inventory (modsley) Drug therapy + control group 2007 Bakhtavar PTSD Iran TCQ Control: Only drug therapy 2010 Bahadori Social phobia 2010 Bahadori Social phobia 2010 Bahadori Social phobia Iran SPSAQ FNE scale Control: Waiting list Iran FNE scale Control: Waiting list Iran MCQ 1 (positive) MCQ2 (cognitive confidence) 2010 Abdolahzadeh Obsession Y-BOCS MCQ30 DASS-21 TCQ (anxiety) STAI-T 2012 Andouz Pure obsession 2010 Afshari Panic disorder UK Netherlands OCI-R MCQ Y-BOCS TFI Panic belief questionnaire Control: Waiting list MCT: 54 IUT: 52 DT: 20 MCT: 7 Fluvoxamine: 7 MCT: 12 Control: 12 MCT: 20 Drug: 20 Control: 20 MCT: 15 Control: 15 MCT:10 Control:9 MCT: 10 Control: 9 MCT: 10 Control: 9 Drug MCT: 8 Control: 8 Multiple baseline: Single subject design Control: Drug MCT: 10 Control: 10 Controlled 6 Controlled (Continued)
4 Table 1: Continued Title Year First author Disorder Site of the study Treating posttraumatic stress disorder with metacognitive therapy: A preliminary controlled Effect of metacognitive therapy on anxiety and metacognitive components in GAD patients Comparison of the effectiveness of behavioral-cognitive and behavioral-metacognitive approaches in patients with OCD Tests Control Sample size Type of study 2012 Wells PTSD Iran PDS Scale; Foa Control: DT MCT: 10 IES; Horowitz BAI Assessor rating TCQ Control: Atash GAD Iran BAI MWQ (MCQ-30) MCQ1 MCQ2 MCQ3 MCQ4 MCQ5 Control: No treatment MCT: 10 Control: Akrami OCD Iran Maudsley Control: CBT MCT: 11 Control: 18 Controlled Controlled a MCQ1 = Positive belief; b MCQ2 = Negative belief; c MCQ3 = Low cognitive confidence; d MCQ4 = Superstitious themes; e MCQ5 = Cognitive self-awareness. PSWQ = Penn-State Worry Questionnaire; = Beck Depression Inventory; BAI = Beck Anxiety Inventory; MCQ = Metacognitions Questionnaire; MCT = Metacognitive therapy; GAD = Generalized anxiety disorder; OCD = Obsessive-compulsive disorder; PTSD = Posttraumatic stress disorder; SCL-90 = Symptom Checklist 90; IUS = Intolerance-of-Uncertainty Scale; DT = Delayed treatment; CBT = Cognitive and behavioral therapies; TFI = Thought-fusion inventory; TCQ = Thought Control Questionnaire; SPSAQ = Social Phobia Symptoms Assessment Questioner; FNE scale = Fears of Negative Evaluation scale; Y-BOCS = Yale-Brown Obsessive Compulsive Scale; DASS-21 = Depression Anxiety Stress Scale 21; OCI-R = Obsessive-Compulsive Inventory Revised; PDS = Posttraumatic Stress Diagnostic; IES = Impact of Events Scale; MWQ = Meta-worry Questionnaire; IUT = Intoleranceof-uncertainty therapy; = Randomized controlled ; AR = Applied relaxation; STAI-T = Trait version of the State-Trait Anxiety Inventory Table 2: Quality assessment of the included studies according to Oxford Center for Evidence Based Medicine checklist for s Studies A pilot randomized of MCT versus AR in the treatment of adults with generalized anxiety disorder on the effectiveness of MCT and intolerance-of-uncertainty therapy for generalized anxiety disorder Comparison of MCT, fluvoxamine and combined treatment in Improving metacognitive beliefs and subjective distress of patients with obsessive-compulsive disorder Effect of Wells MCT on thought fusion in patients with obsessive compulsive disorder The effect of metacognitive and drug therapies on metacognitive beliefs of disease with obsessive-compulsive disorder Efficacy of metacognitive behavioral therapy in reducing self-punishment in patients with posttraumatic stress disorder 1a. R-Was the assignment of patients to treatments randomized? Randomization by draw sealed envelope from the box Randomization by throwing a dice 1b. R-Were the groups similar at the start of the? 2a. A-Aside from the allocated treatment, were groups treated equally? 2b. A-Were all patients who entered the accounted for? And were they analyzed in the groups to which they were randomized? There was no drop-out from MCT and 10% at 6 m follow-up from AR This study reports intention to treat 126 patients randomized 7 patients from MCT and 4 from IUT lost to follow-up 1 patient in fluvoxamine group and 1 from combined group excluded 3. M-Were measures for assessment outcome objective? outcome: SCID, STAI-T, PSWQ, BAI, outcome: SCID, PSWQ, STAI-T,, SCL-90 Objective measures of outcome: SUDs, MCQ30 outcome: TFI Objective measures of outcome: SCID, MCQ30 outcome: TCQ (Continued) Journal of Research in Medical Sciences September
5 Table 2: Continued Studies Effects of MCT on symptoms of social phobia patients Effects of MCT on symptoms of fear of negative judgments in social phobia patients Effects of MCT on metacognitive beliefs and cognitive confidence in social phobia patients Comparison effect of MCT and drug on obsession Efficacy of metacognitive-behavioral therapy on panic beliefs in female panic patients Treating posttraumatic stress disorder with MCT: A preliminary controlled Effect of MCT on anxiety and metacognitive components in GAD patients Comparison of the effectiveness of behavioral-cognitive and behavioralmetacognitive approaches in patients with OCD The efficacy of MCT on patients suffering from pure obsession 1a. R-Was the assignment of patients to treatments randomized? 1b. R-Were the groups similar at the start of the? 2a. A-Aside from the allocated treatment, were groups treated equally? 2b. A-Were all patients who entered the accounted for? And were they analyzed in the groups to which they were randomized? No No Of 24 patients 2 patients from MCT and 2 from control excluded (20 at last analyzed) 3. M-Were measures for assessment outcome objective? outcome: FNE, SPSAQ objective measures for outcome: FNE outcome: MCQ outcome: MCQ, Y-BOCS, TCQ, DASS,, STAI-T outcome: PBQ outcome: PDS, TCQ,, BAI, IES No No outcome: SCID, MCQ, BAI, MWQ outcome: MOCI Objective measures of outcome:, TFI, SCID, OCI-R, Y-BOCS MCT = Metacognitive therapy; = Randomized controlled ; GAD = Generalized anxiety disorder; OCD = Obsessive-compulsive disorder; AR = Applied relaxation; IUT = Intolerance-of-uncertainty therapy; SCID = Structural Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Dissociative Disorders; PSWQ = Penn-State Worry Questionnaire; = Beck Depression Inventory; BAI = Beck Anxiety Inventory; SCL-90 = Symptom Checklist 90; SUDs = Substance use disorders; MCQ = Metacognitions Questionnaire; TCQ = Thought Control Questionnaire; FNE scale = Fears of Negative Evaluation scale; SPSAQ = Social Phobia Symptoms Assessment Questioner; Y-BOCS = Yale-Brown Obsessive Compulsive Scale; DASS = Depression Anxiety Stress Scale; PBQ = Patient benefit questionnaire; PDS = Posttraumatic Stress Diagnostic; IES = Impact of Events Scale; MWQ = Meta-worry Questionnaire; MOCI = Maudsley Obsessional-Compulsive Inventory; TFI = Thought-fusion inventory; OCI-R = Obsessive-Compulsive Inventory Revised; STAI-T = Trait version of the State-Trait Anxiety Inventory Table 3: Quality assessment of nonrandomized studies according to NewCastle-Ottawa Quality Assessment Scale Studies Description of control group Comparability Objectivity of outcome Comparison effect of MCT and drug on obsession Comparison of the effectiveness of behavioral-cognitive and behavioral-metacognitive approaches in patients with OCD Control group with same diagnosis drawn from different source and exposed to drug therapy Control group drawn from the same community with the same diagnosis but exposed to different treatment (CBT) The efficacy of MCT on patients Every two patient made a pair and suffering from pure obsession role as control for each other OCD = Obsessive-compulsive disorder; CBT = Cognitive and behavioral therapies Study controls for metacognitive beliefs, obsession, depression and anxiety at pretest Study controls for OCD diagnosis and intensity Study controls for OCD diagnosis and intensity, depression Self-report measures Self-report measures Self-report measures Adequacy of follow-up No statement about follow-up No statement about follow-up Follow-up 3 months after treatment 905 Journal of Research in Medical Sciences September 2015
6 Results showed that at posttreatment and at follow-up MCT was superior to AR. [13] van der Heiden et al. compared the effectiveness of MCT and intolerance-of-uncertainty therapy (IUT). These patients were randomly assigned to MCT, IUT, or delayed treatment (DT). With large ES (ranging between 0.94 and 2.39) both MCT and IUT, but not DT, produced significant reductions in GAD symptoms. They also showed that MCT provided better results than IUT. [18] Atash et al. in their study investigated the effectiveness of MCT on anxiety and metacognitive components in GAD patients. Results showed that patients in MCT group in all measures gained better results than the control group. [19] Obsessive-compulsive disorder Five studies evaluated the efficacy of MCT in the OCD patients. Sharreh et al. investigate the efficacy of MCT compare to fluvoxamine and the combination of MCT with fluvoxamine. Their results showed that unlike the fluvoxamine, the MCT and combined treatment led to significant improvements in Metacognitions Questionnaire (MCQ) components and subjective units of distress scale. However, there were no significant differences between MCT and combined therapy. [20] Khorramdel et al. investigated the effect of MCT on thought fusion in OCD patients. The study experimental group showed statistically significant decreases in thought fusion general scores in posttest and follow-up, compared with the control group. [21] Abolghasemi et al. investigated the effect of MCT and drug therapy on metacognitive beliefs of OCD patients. Their results showed that MCT was more effective in reducing symptoms, and modifying dysfunctional metacognitive beliefs than drug therapy. [22] Akrami et al. compared MCT and CBT in the treatment of OCD patients. According to their results, both methods effectively decreased obsessive-compulsive symptoms, however, there was no significant difference between CBT and MCT. [23] Abdolahzadeh et al. compared MCT and drug therapy in an obsession in OCD patients. Their results showed that MCT was more effective than the drug in reducing the severity of obsessions and stress and dysfunctional metacognitive beliefs. On the other hand; for general function, drug therapy produced better results than MCT. [24] Andouz et al. investigated the efficacy of MCT on patients with obsession. Their results indicated that MCT was effective in reducing OCD symptoms and modifying dysfunctional metacognitive and thoughtfusion beliefs. [25] Posttraumatic stress disorder Two of the included studies the MCT effect on PTSD patients. Bakhtavar et al. investigated the efficacy of MCT on reducing self-punishment behaviors in PTSD. Their results showed that MCT was effective in reaching this goal. [26] Wells and Colbear evaluated MCT in treating PTSD patients. Their results indicated that MCT in comparison with control condition led to reductions in PTSD symptoms, depression, and anxiety. [27] Panic disorder Only Afshari et al. investigated MCT on panic beliefs in females suffering from panic disorder. They showed that MCT was effective in reducing panic beliefs compared to the control group. [28] Social phobia Bahadori et al. in three nonduplicate studies investigated the effectiveness of MCT on symptoms of social phobia fear of negative judgments, metacognitive beliefs, and cognitive confidence in patients suffering from social phobia. [10,29,30] Their results showed that MCT had a significant effect in reducing symptoms of social phobia, fear of negative judgments, metacognitive beliefs, and cognitive confidence. Quantitative synthesis (meta-analyses) Three studies had enough information for the quantitative synthesis of MCT effect on GAD. [13,18,19] Figure 2 shows the forest plots of these analyses. Standardized differences in means of psychological test score changes were 7.94 (95% confidence interval: ) (P = 0.007, Q = 10 [P = 0.01], I 2 = 90%), 7.18 ( ) (P = 0.005, Q = 9.2 [P = 0.002], I 2 = 89%), 7.68 ( ) (P = 0.025, Q = 11.5 [P = ], I 2 = 91%) for Penn State Worry Questionnaire (PSWQ), Beck Depression Inventory (), and Beck Anxiety Inventory tests of the posttreatment period. For 12 months posttreatment data the pooled ES were ( ) (P < , Q = 21 [P = ], I 2 = 95%), and ( ) (P < , Q = 5.8 [P = 0.01], I 2 = 82%) for PSWQ and, respectively. Three studies had enough information for quantitative synthesis of the MCT effect on OCD. [20,22,23] Figure 3 shows the forest plot of the analyses. Standardized differences in means of psychological test score changes were ( ) (P < , Q = 0.5 [P = 0.8], I 2 = 0), and ( ) (P < , Q = 25 [P = ], I 2 = 95%) for MCQ global and Maudsley tests, respectively. Finally, two studies had enough information for the quantitative synthesis of the MCT effect on PTSD. [26,27] Figure 4 shows the forest plot of the analysis. Standardized differences in means of psychological test score changes were ( ) (P < , Q = 0.16 [P = 0.68], I 2 = 0%) for Thought Control Questionnaire test. DISCUSSION In this study, we reviewed the available published clinical s of MCT in adults with anxiety disorders. Journal of Research in Medical Sciences September
7 a b Figure 2: (a) Forrest plot of the difference in means of changes in Beck Depression Inventory, Beck Anxiety Inventory, and Penn State Worry Questionnaire after metacognitive therapy in generalized anxiety disorders. (b) Forrest plot of difference in means of changes in Beck Depression Inventory, Beck Anxiety Inventory, and Penn State Worry Questionnaire after metacognitive therapy in generalized anxiety disorders for 12-month posttreatment Figure 3: Forrest plot of the difference in means of changes in Metacognitions Questionnaire and Maudsley after metacognitive therapy in Obsessive-Compulsive Disorder Figure 4: Forrest plot of the difference in means of changes in Thought Control Questionnaire after metacognitive therapy in posttraumatic stress disorder Our results showed that MCT had statistically significant effect on different domains in anxiety disorders. We located clinical s on different anxiety disorders including GAD, OCD, PTSD, specific and social phobia, and panic disorder. All included studies showed better treatment results in the MCT arms compared to the control groups. We also statistically pooled the results across studies (when possible). The meta-analyses also showed that MCT had 907 Journal of Research in Medical Sciences September 2015
8 statistically significant better results compared to the control groups in GAD (both immediately posttreatment and 12 months posttherapy results), OCD, and PTSD (P values ranged < ). Considering the aim of MCT that is gaining more control over the stream of thoughts particularly in anxiety provoking situations, and the nature of anxiety disorders (damage of natural information processing), it seems that MCT can be effective via modification of maladaptive metacognitive beliefs and facilitation of information processing. MCT gives the opportunity to patients to confront effectively with their beliefs about their disorders. In addition, the recovery rates and magnitude of change in MCT demonstrate that this therapy can be a highly effective treatment. The results of our systematic review also provide additional support for the relevance of Wells metacognitive model to the treatment and understanding of anxiety disorders. [10,21,22] Thus far, several other systematic reviews have been published on psychotherapy for anxiety disorders in children and adolescents. For example, Watson and Rees conducted a meta-analysis on randomized, controlled treatment s of pediatric OCD. Random effects modeling yielded statistically significant pooled ES estimates for pharmacotherapy (ES = 0.48, P < ) and cognitive-behavior therapy (ES = 1.45, P = 0.002). CBT showed a greater ES than pharmacotherapy. [31] In another study, Reynolds et al. conducted a metaanalytic review on psychotherapy for anxiety in children and adolescents. Psychological therapy for anxiety in children and adolescents was moderately effective overall, but ES were small to medium when psychological therapy was compared to an active control condition. The ES for non-cbt interventions was not statistically significant. [32] There are also several meta-analyses that investigated the effectiveness of CBT for anxiety disorders. For example, Butler et al. review 16 meta-analyses of CBT for different disorders. This review suggested that CBT is highly effective for adult unipolar depression, adolescent unipolar depression, GAD, panic disorder with or without agoraphobia, social phobia, PTSD, and childhood depressive and anxiety disorders. The comparison-weighted grand mean ES for these disorders, when compared to notreatment, waitlist, or placebo controls, was 0.95 (standard deviation [SD] = 0.08). Statistically significant evidence for long-term effectiveness was also found for depression, generalized anxiety, panic, social phobia, OCD, sexual offending, schizophrenia, and childhood internalizing disorders. [33] Aside these studies that conducted meta-analyses on CBT and psychotherapy for anxiety disorders, we could not find any systematic review on MCT for anxiety disorders. Limitations Our systematic review had several limitations that should be taken into account while interpreting the results. First of all, the number of studies was limited which forced us to include both randomized and non-s. This can limit the validity of our systematic review although only four of the included studies were nonrandomized. Our results were further limited by the quality of the included studies as most studies did not report the loss to follow-up and did not report on the intention to treat basis. We cannot use double-blind design for our study because, psychological therapy needs to be delivered by therapists who are not blind to the treatment, and this is a limitation. Another important limitation is the heterogeneity and quality of reporting in the included studies. The psychological tests used for evaluation of treatment effect varies considerably across the studies and limited the extraction of useful data. In addition, almost all of the included studies the averages and SDs of pre- and post-psychological tests in the treatment and control arms and in fact differences in pre- and posttreatment data were not compared between the MCT and control groups. CONCLUSION Based on the results of our systematic review, MCT seems to be an effective treatment for anxiety disorders and can effectively control their psychological problems. However, due to low number of the included studies and poor quality of their reporting, our results should be interpreted with caution. Further large studies with consistent design and better quality of report are needed in order to validate the results of our review. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest. AUTHOR S CONTRIBUTION RS: analysis of the results, manuscript revision, writing of discussion. NM: writing of discussion, method, manuscript revision. LZM: analysis of the results. NA: (corresponding author), articles search, preparing the tables, writing of introduction, and manuscript revision. HS: preparing the tables. Journal of Research in Medical Sciences September
9 REFERENCES 1. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007;146: Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62: Available from: 4. Lépine JP. The epidemiology of anxiety disorders: Prevalence and societal costs. J Clin Psychiatry 2002;63 Suppl 14: van Balkom AJ, van Oppen P, Vermeulen AW, van Dyck R, Nauta MC, Vorst HC. A meta-analysis on the treatment of obsessive-compulsive disorder: A comparison of antidepressants, behaviour, and cognitive therapy. Clin Psychol Rev 1994;14: Rees CS, van Koesveld KE. An open of group metacognitive therapy for obsessive-compulsive disorder. J Behav Ther Exp Psychiatry 2008;39: Brewin CR. Understanding cognitive behaviour therapy: A retrieval competition account. Behav Res Ther 2006;44: Wells A, Matthews G. Modelling cognition in emotional disorder: The S-REF model. Behav Res Ther 1996;34: Wells A, Papageorgiou C. Relationships between worry, obsessivecompulsive symptoms and metacognitive beliefs. Behav Res Ther 1998;36: Bahadori MH, Jahanbakhsh M, Kalantari M, Molavi H. Effects of metacognitive therapy on symptoms of social phobia patients. Armaghane Danesh 2010;1: Shareh H, Gharraee B, Atef-Vahid MK, Eftekhar M. Metacognitive therapy (MCT), fluvoxamine, and combined treatment in improving obsessive-compulsive, depressive and anxiety symptoms in patients with obsessive-compulsive disorder (OCD). Iran J Psychiatry Behav Sci 2005;4: Wells A, Sembi S. Metacognitive therapy for PTSD: A preliminary investigation of a new brief treatment. J Behav Ther Exp Psychiatry 2004;35: Wells A, Welford M, King P, Papageorgiou C, Wisely J, Mendel E. A pilot randomized of metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder. Behav Res Ther 2010;48: Wells A, King P. Metacognitive therapy for generalized anxiety disorder: An open. J Behav Ther Exp Psychiatry 2006;37: Fisher PL, Wells A. Metacognitive therapy for obsessivecompulsive disorder: A case series. J Behav Ther Exp Psychiatry 2008;39: DerSimonian R, Laird N. Meta-analysis in clinical s. Control Clin Trials 1986;7: OCEBM Levels of EvidenceWorking Group. The Oxford Levels of Evidence 2. Oxford Centre for Evidence-Based Medicine. Available from: [Last accessed on 2015 Jul]. 18. van der Heiden C, Muris P, van der Molen HT. Randomized controlled on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder. Behav Res Ther 2012;50: Atash SS, Rafienia P, Najafi M. Effect of metacognitive therapy on anxiety and meta cognitive components in GAD patients. Clin Psychol J 2012;4: Sharreh H, Gharaie B, Vahid MA. Comparison of metacognitive therapy, fluvoxamine and combined treatment in improving metacognitive beliefs and subjective distress of patients with obsessive-compulsive disorder. Adv Cogn Sci 2010;12: Khorramdel K, Neshatdoost HT, Molavi H, Amiri SH, Bahrami F. Effect of wells metacognitive therapy on thought fusion in patients with obsessive compulsive disorder. J Fundam Ment Health 2010;12: Abolghasemi A, Hassanali-Zade M, Kazemi R, Narimani M. The effect of metacognitive and drug therapieson metacognitive beliefs of disease with obsessive-compulsive disorder. J Behav Sci 2011;4: Akrami N, Kalantari M, Oreyzi HR, Abedi MR, Maroofi M. Comparison of the effectiveness of behavioural-cognitive & behavioural-metacognitive approaches in patients with obsessivecompulsive disorder (OCD). J Clin Psychol 2010;2: Abdolahzadeh F, Javanbakht M, Abdolahzadeh H. Comparison effect of meta cognitive therapy and drug on obsession. J Sabzevar Univ Med Sci 2011;18: Andouz Z, Dolatshahi B, Moshtagh N, Dadkhah A. The efficacy of metacognitive therapy on patients suffering from pure obsession. Iran J Psychiatry 2012;7: Bakhtavar, E, Neshat-Doost H, Molavi H, Bahrami F. Efficacy of meta cognitive behavioral therapy in reducing self-punishment in patients with posttraumatic stress disorder. J Res Behav Sci 2007;5: Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: A preliminary controlled. J Clin Psychol 2012;68: Afshari M, Neshat Doost H, Bahrami F, Afshar H. Efficacy of metacognitive behavioral therapy on panic beliefs in female panic patients. Arak Med Univ J 2010;13: Bahadori MH, Jahanbakhsh M, Kajbaf M, Faramarzi S. Effects of metacognitive therapy on metacognitive beliefs and cognitive confidence in social phobia patients. J Clin Psychol 2011;1: Bahadori MH, Kalantari M, Molavi H, Jahanbakhsh M, Jamshidi A. Effects of metacognitive therapy on symptoms of fear of negative judgements in social phobia patients. J Mazandaran Univ Med Sci 2010;21: Watson HJ, Rees CS. Meta-analysis of randomized, controlled treatment s for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 2008;49: Reynolds S, Wilson C, Austin J, Hooper L. Effects of psychotherapy for anxiety in children and adolescents: A meta-analytic review. Clin Psychol Rev 2012;32: Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev 2006;26: Journal of Research in Medical Sciences September 2015
Metacognitive therapy for generalized anxiety disorder: An open trial
Journal of Behavior Therapy and Experimental Psychiatry 37 (2006) 206 212 www.elsevier.com/locate/jbtep Metacognitive therapy for generalized anxiety disorder: An open trial Adrian Wells a,, Paul King
More informationGMCT MDD RRS MANCOVA
Email: hsharreh@yahoo.com.au GMCT MDD MCQ-30 BDI-II RRS MANCOVA P< MDD: Major MCT: Metacognitive Therapy Depressive Disorder DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders-4th ed. Text
More informationComparing Metacognitive Therapy with Cognitive Therapy on Reducing Test Anxiety and Meta-worry in Students
Comparing Metacognitive Therapy with Cognitive Therapy on Reducing Test Anxiety and Meta-worry in Students Fahimeh Ghahvechi-Hosseini 1*, Ali Fathi Ashtiani 1, Mojtaba Satkin 1 1. Behavioral Sciences Research
More informationAbass Abolghasemi, PhD Department of Psychology University of Mohaghegh Ardabili. Fridoon Pakpoori. University of Mohaghegh Ardabili
IPA International Journal of Psychology Vol. 6, No. 2, Summer & Fall 2012 PP. 47-65 Iranian Psychological Association The Effects of Meta-Cognitive and Cognitive- Behavioral Therapies on Anxious Thoughts
More informationJamie A. Micco, PhD APPLYING EXPOSURE AND RESPONSE PREVENTION TO YOUTH WITH PANDAS
APPLYING EXPOSURE AND RESPONSE PREVENTION TO YOUTH WITH PANDAS Jamie A. Micco, PhD Director, Intensive Outpatient Service Child and Adolescent Cognitive Behavioral Therapy Program Massachusetts General
More informationPsychometric Properties of Thought Fusion Instrument (TFI) in Students
7-78 89 Iranian Journal of Psychiatry and Clinical Psychology, Vol. 6, No., Spring 00, 7-78 Short Scientific Article Psychometric Properties of Thought Fusion Instrument (TFI) in Students Kazem Khoramdel*,
More informationObsessive Compulsive Disorder: Advances in Psychotherapy
Obsessive Compulsive Disorder: Advances in Psychotherapy Question from chapter 1 1) All the following are Common obsessions EXCEPT a) Fear of becoming someone else b) Unwanted violent impulses c) Fear
More informationThe Comparison of Acceptance and Commitment Therapy with Selective Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder
Zahedan Journal of Research in Medical Sciences Journal homepage: www.zjrms.ir The Comparison of Acceptance and Commitment Therapy with Selective Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive
More informationAssessment in Integrated Care. J. Patrick Mooney, Ph.D.
Assessment in Integrated Care J. Patrick Mooney, Ph.D. Purpose of assessment in integrated care: Assessment provides feedback to promote individual and group learning and change. Physicians Mental health
More informationOriginal Article. (Received: 19 Apr 2013; Revised: 7 Oct 2013; Accepted: 7 Apr 2014)
Original Article A Comparative Study of Thought Fusion Beliefs and Thought Control Strategies in Patient with Obsessive-Compulsive Disorder, Major Depressive Disorder and Normal People Ahmad Amiri Pichakolaei
More informationThe Effect of Metacognitive Therapy on Traumatic Stress Disorder Symptoms in Survivors of Accidents in Shahr-e-Kord
Zahedan Journal of Research in Medical Sciences Journal homepage: www.zjrms.ir The Effect of Metacognitive Therapy on Traumatic Stress Disorder Symptoms in Survivors of Accidents in Shahr-e-Kord Aliakbar
More informationManagement Science Letters
Management Science Letters 3 (2013) 1659 1664 Contents lists available at GrowingScience Management Science Letters homepage: www.growingscience.com/msl The effectiveness of worry exposure in treating
More informationWHY TRANSDIAGNOSTIC TREATMENTS?
TRANSDIAGNOSTIC TREATMENTS FOR ANXIETY DISORDERS Martin M. Antony, PhD, ABPP Professor of Psychology, Ryerson University, Toronto Outline Why Transdiagnostic Treatments? Transdiagnostic Treatment Protocols
More informationChapter 6 Psychoeducation for depression, anxiety and psychological distress: a meta-analysis
Chapter 6 Psychoeducation for depression, anxiety and psychological distress: a meta-analysis Published: Donker, T., Griffiths, K.M., Cuijpers, P., Christensen, H., 2009. Psychoeducation for depression
More informationBackground Paper: Obsessive Compulsive Disorder. Kristen Thomas. University of Pittsburgh
Background Paper: Obsessive Compulsive Disorder Kristen Thomas University of Pittsburgh December 2011 2 According to the DSM-IV, obsessive compulsive disorder (OCD) will be diagnosed when the child displays
More informationTreatment of Anxiety as a Cooccurring Disorder
Treatment of Anxiety as a Cooccurring Disorder John J. Arnold, Ph.D., Sanctuary at Lake Chelan Community Hospital Presented at the 2016 Washington Behavioral Healthcare Conference Learning Objectives Learn
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationEffectiveness of Meta-Cognitive and Cognitive-Behavioral Therapy in Patients with Major Depressive Disorder
Original Article Effectiveness of Meta-Cognitive and Cognitive-Behavioral Therapy in Patients with Major Depressive Disorder Ahmad Ashouri PhD *, Mohammad-Kazem Atef-Vahid PhD *, Banafsheh Gharaee PhD
More informationName: Period: Chapter 14 Reading Guide Psychological Disorders
Name: Period: Chapter 14 Reading Guide Psychological Disorders Introduction to Psychological Disorders (pg. 593-600) 1. List AND describe the 3 definitions of abnormal. A. Understanding Psychological Disorders
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Age as factor in selective mutism, 623 as factor in social phobia, 623 Agoraphobia, 593 600 described, 594 596 DSM-V changes related to,
More informationAnxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when
Anxiety s J. H. Atkinson, M.D. HIV Neurobehavioral Research Center University of California, San Diego Department of Psychiatry & Veterans Affairs Healthcare System, San Diego Materials courtesy of Dr.
More informationComparison and the Effectiveness of Dialectical Behavior Therapy on Obsessive-Compulsive Disorder
J. Appl. Environ. Biol. Sci., ()38-390, 201 201, TextRoad Publication ISSN: 2090-4274 Journal of Applied Environmental and Biological Sciences www.textroad.com Comparison and the Effectiveness of Dialectical
More informationJournal of Science and today's world 2013, volume 2, issue 1, pages: 83-93
Scholar Journal Available online: www.journalsci.com Journal of Science and today's world ISSN 2322-326x Research Article A Comparison of Metacognition in Schizophrenic and Anxiety Disorder Patients and
More informationCBT Treatment. Obsessive Compulsive Disorder
CBT Treatment Obsessive Compulsive Disorder 1 OCD DEFINITION AND DIAGNOSIS NORMAL WORRIES & COMPULSIONS DYSFUNCTIONAL/ABNORMAL OBSESSIONS DSM IV DIAGNOSIS 2 OCD DIAGNOSIS DSM IV & ICD 10 A significant
More informationCognitive Behavioural Psychotherapy for Anxiety Disorders MODULE CODE LEVEL 7 CREDITS 15 ECTS CREDITS VALUE FACULTY
MODULE DESCRIPTOR TITLE Cognitive Behavioural Psychotherapy for Anxiety Disorders MODULE CODE 66-700641 LEVEL 7 CREDITS 15 ECTS CREDITS VALUE FACULTY HWB DEPARTMENT Nursing & Midwifery SUBJECT GROUP DATE
More informationEfficacy of self-help manuals for anxiety disorders in primary care: a systematic review
The Author (2005). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org doi:10.1093/fampra/cmh708 Family Practice Advance Access
More information(This is a sample cover image for this issue. The actual cover is not yet available at this time.)
(This is a sample cover image for this issue. The actual cover is not yet available at this time.) This article appeared in a journal published by Elsevier. The attached copy is furnished to the author
More informationThe Role of Fusion Beliefs and Metacognitions in Obsessive Compulsive Symptoms in General Population
The Role of Fusion Beliefs and Metacognitions in Obsessive Compulsive Symptoms in General Population Shahram Mohammadkhani 1* 1. Department of Psychology, Faculty of Psycholgy & Educational Sciences, Kharazmi
More informationFabrizio Didonna, Paolo Zordan, Elena Prunetti, Denise Rigoni, Marzia Zorzi, Marco Bateni Unit for Anxiety and Mood Disorders Unit for Personality
35th International Congress of SPR 16-19 June 2004 Roma - Italy Clinical features of obsessive symptoms in Borderline Personality Disorders and Obsessive Compulsive Disorders: Differences and overlapping
More informationAn adult version of the Screen for Child Anxiety Related Emotional Disorders (SCARED-A)
Netherlands Journal of Psychology / SCARED adult version 81 An adult version of the Screen for Child Anxiety Related Emotional Disorders (SCARED-A) Many questionnaires exist for measuring anxiety; however,
More informationINSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures
PHQ and GAD-7 Instructions P. 1/9 INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures TOPIC PAGES Background 1 Coding and Scoring 2, 4, 5 Versions 3 Use as Severity
More informationTreating Children and Adolescents with PTSD. William Yule Prague March 2014
Treating Children and Adolescents with PTSD William Yule Prague March 2014 In the beginning. When DSM III first identified PTSD, it was thought that children would rarely show it Why did professionals
More informationPsychological treatment of obsessive compulsive disorder
Psychological treatment of obsessive compulsive disorder Paul M Salkovskis Abstract NICE guidelines recommend psychological treatment (cognitive behavioural therapy, involving major elements of exposure
More informationTargeting cognitive dysfunction: Metacognitive Therapy for depression
Targeting cognitive dysfunction: Metacognitive Therapy for depression Jennifer Jordan 1, Janet Carter 2, Virginia McIntosh, Kumari Fernando, Richard Porter, Cameron Lacey, Roger Mulder, Peter Joyce 1 University
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update 1 Guideline title Anxiety: management of generalised anxiety disorder in adults in primary, secondary and community care (update)
More informationLet s Talk About Treatment
What Doesn t Work Let s Talk About Treatment Lisa R. Terry, LPC What we ve tried Talk therapy- You can t talk you way out of a medical disorder Play Therapy Family Therapy Psychoanalysis While these are
More informationPathways to Inflated Responsibility Beliefs in Adolescent Obsessive-Compulsive Disorder: A Preliminary Investigation
Behavioural and Cognitive Psychotherapy, 2011, 39, 229 234 First published online 23 November 2010 doi:10.1017/s1352465810000810 Pathways to Inflated Responsibility Beliefs in Adolescent Obsessive-Compulsive
More informationThe development of cognitivebehavioral. A Cognitive-Behavioral Group for Patients With Various Anxiety Disorders
A Cognitive-Behavioral Group for Patients With Various Anxiety Disorders David H. Erickson, Ph.D. Amy S. Janeck, Ph.D. Karen Tallman, Ph.D. Objective: Cognitive-behavioral therapy (CBT) protocols for each
More informationComorbidity of Depression and Other Diseases
Comorbidity of Depression and Other Diseases JMAJ 44(5): 225 229, 2001 Masaru MIMURA Associate Professor, Department of Psychiatry, Showa University, School of Medicine Abstract: This paper outlines the
More informationCBT FOR ANXIETY (CBT-A): WHAT CAN I DO WITH MY PATIENT INSTEAD OF GIVING THEM A PRN BENZODIAZEPINE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences CBT FOR ANXIETY (CBT-A): WHAT CAN I DO WITH MY PATIENT INSTEAD OF GIVING THEM A PRN BENZODIAZEPINE PATRICK J. RAUE,
More informationDigitizing Mental Health Support Through Internet- Delivered Cognitive Behavioral Health (icbt) Technology
Digitizing Mental Health Support Through Internet- Delivered Cognitive Behavioral Health (icbt) Technology Session 207, Thursday, February 14, 2019 Joe Blomeley, Senior Vice President, Public Sector and
More informationAnxiety Disorders: First aid and when to refer on
Anxiety Disorders: First aid and when to refer on Presenter: Dr Roger Singh, Consultant Psychiatrist, ABT service, Hillingdon Educational resources from NICE, 2011 NICE clinical guideline 113 What is anxiety?
More informationThe Validation of a New Obsessive-Compulsive Disorder Scale: The Obsessive-Compulsive Inventory
Psychological Assessment 1998. Vol. 10, No. 3. 206-214 Copyright 1998 by the American Psychological Association, Inc. 1040-3590/98/S3.00 The Validation of a New Obsessive-Compulsive Disorder Scale: The
More informationA Comparative Study of Obsessive Beliefs in Obsessive-Compulsive Disorder, Anxiety Disorder Patients and a Normal Group
ORIGINAL ARTICLE A Comparative Study of Obsessive Beliefs in Obsessive-Compulsive Disorder, Anxiety Disorder Patients and a Normal Group Giti Shams 1 and Irena Milosevic 2 1 Department of Psychiatry, Tehran
More informationGraduate thesis, PSYPRO4100 By: Draco Jon Torstein Kvistedal
Graduate thesis, PSYPRO4100 By: Draco Jon Torstein Kvistedal A randomized controlled trial of metacognitive therapy vs. cognitive behavioral therapy vs. waiting list in the treatment of adults with generalized
More informationDiffusing the Stress in Financial Distress: The Intersection of Bankruptcy and Mental Health
Diffusing the Stress in Financial Distress: The Intersection of Bankruptcy and Mental Health Moderator: Hon. Laura Taylor Swain (S.D. N.Y.), New York, NY Panelists: Prof. Richard A. Friedman, M.D., Weill
More informationSupplementary Online Content
Supplementary Online Content Weitz ES, Hollon SD, Twisk J, et al. Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual
More informationAnxiety. DISORDERs? What ARE ANXIETY. What Are Anxiety Disorders? Physical Symptoms. Psychological Symptoms
PRESENTS What ARE Anxiety s? w orry stress payments headache ANXIETY work bills What Are Anxiety Disorders? Individuals with an anxiety disorder can experience psychological or physical symptoms, or both.
More informationFactor Structure, Validity and Reliability of the Modified Yale-Brown Obsessive Compulsive Scale for Body Dysmorphic Disorder in Students
-0 Iranian Journal of Psychiatry and Clinical Psychology, Vol., No., Winter 00, - 0 - - Original Article Factor Structure, Validity and Reliability of the Modified Yale-Brown Obsessive Compulsive Scale
More informationLoud noises, loss of support, heights, strangers, separation (in the present) Animals, the dark, storms, imaginary creatures, anticipatory anxiety
Anxiety is normal, adaptive, and protective Anxiety varies in intensity from person to person High levels of anxiety are problematic Lowering the volume, not changing the station Developmental Stage Infancy
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationCBT FOR PRIMARY CARE PART 1: BACKGROUND AND THEORY DISCLOSURES
CBT FOR PRIMARY CARE PART 1: BACKGROUND AND THEORY Neil Skolnik, M.D. Professor of Family and Community Medicine Temple University School of Medicine Associate Director Family Medicine Residency Program
More informationAnxiety in Youth: Identification, Management, & Referral
Anxiety in Youth: Identification, Management, & Referral Martin E. Franklin, Ph.D. Associate Professor of Psychiatry University of Pennsylvania School of Medicine Prelude to the Talk: Anxiety & Its Disorders
More informationA randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD)
Eur Child Adolesc Psychiatry (2009) 18:131 135 DOI 10.1007/s00787-007-0634-z ORIGINAL CONTRIBUTION Javad Alaghband-Rad Mitra Hakimshooshtary A randomized controlled clinical trial of Citalopram versus
More informationSpecific Issues in Pediatric OCD: Treatment and Adulthood Outcome
Specific Issues in Pediatric OCD: Treatment and Adulthood Outcome Michael H. Bloch M.D., M.S. Assistant Director, Yale OCD Clinic Assistant Professor, Yale Child Study Center Michael.bloch@yale.edu Objectives
More informationJournal of Applied Science and Agriculture
AENSI Journals Journal of Applied Science and Agriculture ISSN 1816-9112 Journal home page: www.aensiweb.com/jasa/index.html Comparing of Thought-Action Fusion (TAF) and Worry between Patients with GAD,
More informationDBT Modification/ Intervention
Table 2. Published Studies Examining Application of Inpatient DBT (alphabetical listing) Citation Inpatient Setting DBT Sample Comparison Sample DBT Modification/ Intervention Outcome Measures Results
More informationINDEX. P. 2 Provisional List of Potentially Harmful Therapies (Adapted from Lilienfeld, 2007)
Comprehensive List of Currently-Identified Potentially Harmful (PHTs) and Empirically Supported Psychological Treatments (ESTs) for Adults, Adolescents, and Children INDEX P. 2 Provisional List of Potentially
More informationBrief Psychiatric History and Mental Status Examination
2 Brief Psychiatric History and Mental Status Examination John R. Vanin A comprehensive medical evaluation includes a thorough history, physical examination, and appropriate laboratory, imaging and other
More informationMetacognition and Depression, State Anxiety and Trait Anxiety Symptoms
Metacognition and Depression, State Anxiety and Trait Anxiety Symptoms Baharak Delavar 1*, Behroz Dolatshahi 2,3, Mohsen Nouri 4, Khalil Aryanfar 5 1. MSc in Psicology, Department of Psychology, University
More informationANXIETY: SCREENING, DIFFERENTIAL DIAGNOSIS, TREATMENT MONITORING
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences ANXIETY: SCREENING, DIFFERENTIAL DIAGNOSIS, TREATMENT MONITORING DEB COWLEY MD OCTOBER 20, 2016 OBJECTIVES At the
More informationMULTIDISCIPLINARY TREATMENT OF ANXIETY DISORDERS
MULTIDISCIPLINARY TREATMENT OF ANXIETY DISORDERS ANDREW ROSEN, PHD, ABPP, FAACP THE CENTER FOR TREATMENT OF ANXIETY AND MOOD DISORDERS THE CHILDREN S CENTER FOR PSYCHIATRY, PSYCHOLOGY AND RELATED SERVICES
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Personality Disorder: the clinical management of borderline personality disorder 1.1 Short title Borderline personality disorder
More informationFive Changes in DSM 5 Principles for Primary Care. Tom Janzen, M.D. STEGH Mental Health May 14, 2014
Five Changes in DSM 5 Principles for Primary Care Tom Janzen, M.D. STEGH Mental Health May 14, 2014 Overall Learning Objectives Review 5 changes to DSM 5 which have significance for Family Physicians Examine
More informationIncreasing the Recognition of Generalized Anxiety Disorder in Primary Care
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2015 Increasing the Recognition of Generalized Anxiety Disorder in Primary Care Sarah Rosner
More informationPublication trends in individual anxiety disorders:
Publication trends in individual anxiety disorders: 1980-2015 Author Boschen, Mark Published 2008 Journal Title Journal of anxiety disorders DOI https://doi.org/10.1016/j.janxdis.2007.04.004 Copyright
More informationGeneral Psychology. Chapter Outline. Psychological Disorders 4/28/2013. Psychological Disorders: Maladaptive patterns of behavior that cause distress
General Psychology Jeffrey D. Leitzel, Ph.D. Chapter 1: Behavioral (Psychological) Disorders 1 Chapter Outline Defining abnormality Historical perspectives on abnormality Classifying/identifying disorders
More informationAppendix 15c: Study characteristics - high-intensity psychological interventions and combination therapies
Appendix 15c: Study characteristics - high-intensity psychological interventions and combination therapies In the treatment of GAD, what are the risks and benefits associated with high-intensity psychological
More informationCHILDHOOD OCD: RESEARCH AND CLINIC
Syllabus CHILDHOOD OCD: RESEARCH AND CLINIC - 37923 Last update 02-12-2013 HU Credits: 4 Degree/Cycle: 2nd degree (Master) Responsible Department: School of Education Academic year: 1 Semester: Yearly
More informationAdvocating for people with mental health needs and developmental disability GLOSSARY
Advocating for people with mental health needs and developmental disability GLOSSARY Accrued deficits: The delays or lack of development in emotional, social, academic, or behavioral skills that a child
More informationFeeling nervous? Class Objectives: 9/3/2008. Chapter 4-Anxiety Disorders. Discuss the paper guidelines
Feeling nervous? Chapter 4-Anxiety Disorders Class Objectives: Discuss the paper guidelines How are anxiety, fear and panic similar? Different? What is GAD? Abnormal Psychology (PSY 210) Position Paper
More informationContemporary Psychiatric-Mental Health Nursing Third Edition. Theories: Anxiety Disorders. Theories: Anxiety Disorders (cont'd) 10/2/2014
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 18 Anxiety Disorders Theories: Anxiety Disorders Biological changes in the brain Neurotransmitters are associated with anxiety. low
More informationDysfunctional Metacognitive Beliefs in Body Dysmorphic Disorder
Global Journal of Health Science; Vol. 8, No. 3; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Dysfunctional Metacognitive Beliefs in Body Dysmorphic Disorder
More informationCURRICULUM VITAE. Sara M. Witcraft, B.A. (Last Revised January 2018)
CURRICULUM VITAE Witcraft Vitae 1 Sara M. Witcraft, B.A. (Last Revised January 2018) PROFESSIONAL ADDRESS Department of Psychology 302E Peabody Hall P.O. Box 1848 University, MS 38677-1848 Email: switcraf@go.olemiss.edu
More informationPsychological Therapies: Effectiveness, Efficiency and Large Scale Dissemination
Psychological Therapies: Effectiveness, Efficiency and Large Scale Dissemination David M Clark University of Oxford, UK 23 rd October 2013 Outline of Talk How effective are psychological therapies? Novel
More informationIAPT for Adults: Progress to Date & Next Steps. David M Clark National Clinical & Informatics Advisor University of Oxford
IAPT for Adults: Progress to Date & Next Steps David M Clark National Clinical & Informatics Advisor University of Oxford (david.clark@psy.ox.ac.uk) What is IAPT? An English Programme that aims to vastly
More informationAnxiety Disorders. Program Support Notes by: Jo Basnett B.Ed. Executive Producer: Simon Garner B.Ed, Dip Management
Program Support Notes by: Jo Basnett B.Ed Executive Producer: Simon Garner B.Ed, Dip Management You may download and print one copy of these support notes from our website for your reference. Further copying
More informationChapter 5 - Anxiety Disorders
Chapter 5 - Anxiety Disorders I. PANIC DISORDER A. Description - with &without Agoraphobia 1. PD w/o Agora - panic attacks - feeling of imminent death - numerous symptoms (racing heart, sweating, dizziness)
More informationNAME. Montefiore Medical Center/Albert Einstein College of Medicine APA Accredited Pre-doctoral Internship (Clinical Psychology)
University of Pennsylvania Department of Psychology ADDRESS PHONE EMAIL NAME EDUCATION Montefiore Medical Center/Albert Einstein College of Medicine APA Accredited Pre-doctoral Internship (Clinical Psychology)
More informationUnderstanding anxiety disorders in children
What questions will be covered? Anxiety in Children: What GPs need to know PROFESSOR JENNIE HUDSON, Department of Psychology Understanding anxiety disorders in children Are Anxiety Disorders something
More informationCADTH HEALTH TECHNOLOGY ASSESSMENT Cognitive Processing Therapy for Post-traumatic Stress Disorder: A Systematic Review and Meta-analysis
CADTH HEALTH TECHNOLOGY ASSESSMENT Cognitive Processing Therapy for Post-traumatic Stress Disorder: A Systematic Review and Meta-analysis Product Line: Health Technology Assessment Issue Number: 141 Publication
More informationNeuRA Obsessive-compulsive disorders October 2017
Introduction (OCDs) involve persistent and intrusive thoughts (obsessions) and repetitive actions (compulsions). The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines
More informationThe Practitioner Scholar: Journal of Counseling and Professional Psychology 1 Volume 5, 2016
The Practitioner Scholar: Journal of Counseling and Professional Psychology 1 Assessing the Effectiveness of EMDR in the Treatment of Sexual Trauma Shanika Paylor North Carolina Central University and
More informationAre psychological treatments of panic disorder efficacious?
Are psychological treatments of panic disorder efficacious? Peter Wilhelm 7.3.2018 PD Dr. Peter Wilhelm, Spring 2018 1 Efficacy of Behavioral Treatment of Panic Disorder First randomised controlled trial
More informationAn event where a person is exposed to: death threatened death actual or threatened serious injury actual or threatened sexual violence
By Jo Lunn An event where a person is exposed to: death threatened death actual or threatened serious injury actual or threatened sexual violence Characterized by symptoms of: } Intrusion/re experiencing
More informationAcute Stabilization In A Trauma Program: A Pilot Study. Colin A. Ross, MD. Sean Burns, MA, LLP
In Press, Psychological Trauma Acute Stabilization In A Trauma Program: A Pilot Study Colin A. Ross, MD Sean Burns, MA, LLP Address correspondence to: Colin A. Ross, MD, 1701 Gateway, Suite 349, Richardson,
More informationComorbidity With Substance Abuse P a g e 1
Comorbidity With Substance Abuse P a g e 1 Comorbidity With Substance Abuse Introduction This interesting session provided an overview of recent findings in the diagnosis and treatment of several psychiatric
More informationCognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost effectiveness
For reprint orders, please contact reprints@expert-reviews.com Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost effectiveness Expert Rev. Pharmacoecon.
More informationName. 1. Cultural expectations for "normal" behavior in a particular society influence the understanding of "abnormal behavior.
Chapter 10 Quiz Name Psychological Disorders (Modules 33 & 34) True or False: 1. Cultural expectations for "normal" behavior in a particular society influence the understanding of "abnormal behavior."
More informationTITLE: Aripiprazole for Borderline Personality Disorder: A Review of the Clinical Effectiveness
TITLE: Aripiprazole for Borderline Personality Disorder: A Review of the Clinical Effectiveness DATE: 03 February 2017 Borderline personality disorder (BPD) is characterized by unstable interpersonal relationships,
More informationIntroduction to the Anxiety Disorders. Operational Definitions. Psychiatric Disorders 5/5/2012
Introduction to the Anxiety Disorders Operational Definitions Like love, beauty, truth, wealth, and so many other things, mental disorders are a This does notrob them of their importance Psychiatric Disorders
More informationa guide to cognitivebehavioural (cbt)
a guide to cognitivebehavioural therapy (cbt) Cognitive-behavioural aims to help you to change the way that you think, feel and behave. It is used as a treatment for various mental health and physical
More informationMeasurement of Mental Health among Adolescents at the Population Level (MMAP) Conceptual Framework and Roadmap
Measurement of Mental Health among Adolescents at the Population Level (MMAP) Conceptual Framework and Roadmap The Roadmap to the Measurement of Mental Health among Adolescents at the Population Level
More informationConsecutive mental health patients of a family doctor in Shanghai 6 years experience
Consecutive mental health patients of a family doctor in Shanghai 6 years experience Date: 13 th January 2015 Time: 12:15 Location: UFH Presenter: Lincoln Miyasaka Introduction: The prevalence of generalized
More informationTransdiagnostic Approaches to the Treatment of Anxiety and Emotional Disorders:
Transdiagnostic Approaches to the Treatment of Anxiety and Emotional Disorders: Peter J. Norton, Ph.D. Disclosures Funded by grants and awards from: American Psychological Association National Institute
More informationCOGNITIVE BEHAVIOUR THERAPY 1 (CBT 1)
UEA Doctorate in Clinical Psychology COGNITIVE BEHAVIOUR THERAPY 1 (CBT 1) Module co-ordinator: Dr Ella Beeson 2016 Cohort 2016/17 Module: COGNITIVE BEHAVIOUR THERAPY 1 Module co-ordinator: Dr Ella Beeson
More informationEvidence Summary. Abstract
Evidence Summary Intervention for replacing missing teeth: Alveolar ridge preservation techniques for dental implant site development - evidence summary of Cochrane review Srinivasan Jayaraman Department
More informationSurveillance report Published: 13 April 2017 nice.org.uk. NICE All rights reserved.
Surveillance report 2017 Antisocial behaviour and conduct disorders in children and young people: recognition and management (2013) NICE guideline CG158 Surveillance report Published: 13 April 2017 nice.org.uk
More informationReassuringly Calm? Self-reported patterns of responses to reassurance seeking in Obsessive. Compulsive Disorder
Reassuringly Calm? Self-reported patterns of responses to reassurance seeking in Obsessive Compulsive Disorder Paul M. Salkovskis 1* and Osamu Kobori 2 Running head: Reassurance Seeking in OCD 1 Department
More informationSusan Sprich, Ph.D. Director, CBT Program, MGH
Susan Sprich, Ph.D. Director, CBT Program, MGH Disclosures I receive royalties from Oxford University Press for coauthoring a workbook and therapist guide I receive royalties from Springer for co-editing
More information